[{"orgOrder":0,"company":"H3 Biomedicine Inc","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"H3B-6545","moa":"Estrogen receptor (ESR)","graph1":"Oncology","graph2":"Phase I\/ Phase II","graph3":"H3 Biomedicine Inc","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"H3 Biomedicine Inc \/ Undisclosed","highestDevelopmentStatusID":"7","companyTruncated":"H3 Biomedicine Inc \/ Undisclosed"},{"orgOrder":0,"company":"H3 Biomedicine Inc","sponsor":"Eisai Inc","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"H3B-6527","moa":"FGFR4 messenger RNA (FGFR4 mRNA)","graph1":"Undisclosed","graph2":"Phase I","graph3":"H3 Biomedicine Inc","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Capsule","sponsorNew":"H3 Biomedicine Inc \/ H3 Biomedicine Inc","highestDevelopmentStatusID":"6","companyTruncated":"H3 Biomedicine Inc \/ H3 Biomedicine Inc"},{"orgOrder":0,"company":"H3 Biomedicine Inc","sponsor":"Eisai Inc","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2016","type":"Inapplicable","leadProduct":"H3B-6527","moa":"FGFR4 messenger RNA (FGFR4 mRNA)","graph1":"Oncology","graph2":"Phase I","graph3":"H3 Biomedicine Inc","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"H3 Biomedicine Inc \/ Eisai Inc","highestDevelopmentStatusID":"6","companyTruncated":"H3 Biomedicine Inc \/ Eisai Inc"},{"orgOrder":0,"company":"H3 Biomedicine Inc","sponsor":"Eisai Inc","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"E7766","moa":"Stimulator of interferon genes protein (TMEM173)","graph1":"Oncology","graph2":"Phase I","graph3":"H3 Biomedicine Inc","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Solution","sponsorNew":"H3 Biomedicine Inc \/ H3 Biomedicine Inc","highestDevelopmentStatusID":"6","companyTruncated":"H3 Biomedicine Inc \/ H3 Biomedicine Inc"},{"orgOrder":0,"company":"H3 Biomedicine Inc","sponsor":"Eisai Inc","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"U.S.A","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"E7766","moa":"Stimulator of interferon genes protein (TMEM173)","graph1":"Oncology","graph2":"Phase I","graph3":"H3 Biomedicine Inc","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Solution","sponsorNew":"H3 Biomedicine Inc \/ H3 Biomedicine Inc","highestDevelopmentStatusID":"6","companyTruncated":"H3 Biomedicine Inc \/ H3 Biomedicine Inc"}]